XML 47 R31.htm IDEA: XBRL DOCUMENT v3.22.4
Business Combinations (Tables)
 12 Months Ended
Dec. 31, 2022
Business Combination and Asset Acquisition [Abstract]  
Schedule of Assets Acquired and Liabilities Assumed at the Acquisition Date
The fair value of the assets acquired at the acquisition dates were as follows (in millions):
Identifiable intangible assets: 
Noncompete agreements (useful lives of 2 to 3 years)
$0.9 
Goodwill26.2 
Total assets acquired$27.1 
The fair value of the assets acquired at the acquisition dates were as follows (in millions):
Identifiable intangible assets: 
Noncompete agreements (useful lives of 3 to 5 years)
$1.0 
Trade name (useful life of 20 years)
0.3 
Goodwill8.8 
Other long-term assets0.1 
Total assets acquired$10.2 
The fair value of the assets acquired at the acquisition date were as follows (in millions):
Identifiable intangible assets: 
Noncompete agreements (useful lives of 2 to 3 years)
$0.7 
Trade name (useful life of 20 years)
0.9 
Goodwill9.3 
Total assets acquired$10.9 
Schedule of Business Acquisitions, by Acquisition
Information regarding the net cash paid for the acquisitions during 2022 is as follows (in millions):
Fair value of assets acquired
$0.9 
Goodwill26.2 
Fair value of noncontrolling interest owned by joint venture partner
(27.1)
Net cash paid for acquisitions$— 
Information regarding the net cash paid for the acquisitions during 2021 is as follows (in millions):
Fair value of assets acquired
$1.4 
Goodwill8.8 
Fair value of noncontrolling interest owned by joint venture partner
(9.1)
Net cash paid for acquisitions
$1.1 
Information regarding the net cash paid for the inpatient rehabilitation acquisitions during 2020 is as follows (in millions):
Fair value of assets acquired
$1.6 
Goodwill9.3 
Fair value of noncontrolling interest owned by joint venture partner
(10.9)
Net cash paid for acquisitions
$— 
Schedule of Actual and Pro Forma Results of Operations for Acquisitions
The following table summarizes the results of operations of the above-mentioned acquisitions from the dates of acquisitions included in our consolidated results of operations and the unaudited pro forma results of operations of the combined entity had the dates of the acquisitions been January 1, 2021 (in millions):
Net Operating RevenuesNet Income Attributable to Encompass Health
Acquired entities only: Actual from acquisition date to December 31, 2022$— $— 
Combined entity: Supplemental pro forma from 01/01/2022-12/31/2022 (unaudited)4,369.0 273.7 
Combined entity: Supplemental pro forma from 01/01/2021-12/31/2021 (unaudited)4,039.8 415.3 
The information presented above is for illustrative purposes only and is not necessarily indicative of results that would have been achieved if the acquisitions had occurred as of the beginning of our 2021 period.
The following table summarizes the results of operations of the above mentioned-acquisitions from their respective dates of acquisition included in our consolidated results of operations and the unaudited pro forma results of operations of the combined entity had the date of the acquisitions been January 1, 2020 (in millions):
Net Operating RevenuesNet Income Attributable to Encompass Health
Acquired entities only: Actual from acquisition date to December 31, 2021$— $— 
Combined entity: Supplemental pro forma from 01/01/2021-12/31/2021 (unaudited)4,021.1 412.5 
Combined entity: Supplemental pro forma from 01/01/2020-12/31/2020 (unaudited)3,581.3 285.0 
The following table summarizes the results of operations of the above-mentioned acquisitions from their respective dates of acquisition included in our consolidated results of operations and the unaudited pro forma results of operations of the combined entity had the date of the acquisitions been January 1, 2020 (in millions):
Net Operating RevenuesNet Income Attributable to Encompass Health
Acquired entities only: Actual from acquisition date to December 31, 2020$— $— 
Combined entity: Supplemental pro forma from 01/01/2020-12/31/2020 (unaudited)3,571.9 284.8